We develop proprietary drug formulas in the field of oncology, dermatology and autoimmune diseases

News

28 June 2019

Biotts is looking for money under the skin

A start-up from Wroclaw, in which Leonarto fund has invested, is working on new methods of drug transport into the body. Patients will not have ...

Read

13 June 2019

Biotts – own preparations and drug formulas

Rzeczpospolita: Own preparations and drug formulas based on natural extracts are developed by Biotts – a start-up from Wrocław, which already has ...

Read

24 May 2019

Next Health – Impact in Kraków

Impact is an event where one can get the latest news about the progress of the digital economy from the perspective of business, scientific ...

Read

17 May 2019

Biotts among the winners in Łódź: the CEBioForum

Biotts spent the last two days in Łódź at the CEBioForum. The idea behind the event is to support start-ups and modern technologies in the field ...

Read
 

About BIOTTS

BIOTTS S.A. is a Polish biotechnological company that develops proprietary drug formulas in the field of oncology, dermatology, and autoimmune diseases. The team of Biotts technologists has developed a proprietary technology for obtaining a universal transdermal therapeutic system: MTC-Y. Thanks to the unique properties of the system, it is possible to increase the bioavailability of active substances by several times, allowing active substances to penetrate through skin barriers up to several centimetres, reaching soft tissues and bones. The unique transdermal MTC-Y system can be easily modified to achieve a targeted action in pathologically changed tissues. By increasing the bioavailability of the substance, it is possible to reduce the therapeutic dose, while maintaining the original effect and, at the same time, reducing the side effects. The unique transdermal Biotts system enables the transport of one to several active substances, thanks to which it is possible to design multi-component drugs. Through simple modifications of the system, it is also possible to design medicines with a modified release profile for the medicinal substance.

With more than thirty years of experience, the Research and Development Team is able to effectively create proprietary medicines, solve complex technological problems and create unique solutions to help people all over the world.

BIOTTS S.A. also provides research and development services for pharmaceutical, biotechnological, cosmetic and chemical companies from all over the world.

We have provided the market with a wide variety of solutions, including: a non-aggregating nanocarrier used in the production of vitamin preparations, anti-allergic drugs, semi-solid forms of a drug with a deep penetration carrier, semi-solid forms of a drug accelerating tissue reconstruction, cosmetic products with increased bioavailability based on natural resources, medicinal gels, stabilised and naturally preserved omega acids, and functional food formulas.

BIOTTS S.A.
ul. Krakowska 141-155
50-428 Wrocław
office@botts.com